Global Etoricoxib Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Etoricoxib Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Etoricoxib is a selective COX-2 inhibitor used to relieve dental pain after moderate surgery as a short-term treatment and inflammation and pain symptoms of various forms of arthritis.
Etoricoxib report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Etoricoxib market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Etoricoxib industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Etoricoxib key manufacturers include Morepen Laboratories, Merck & Co, Frosst Iberica SA, Metrochem API, Atom Pharma, Hema Pharmaceuticals, Beijing Tide Pharmaceutical, Qilu Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. Morepen Laboratories, Merck & Co, Frosst Iberica SA are top 3 players and held % sales share in total in 2022.
Etoricoxib can be divided into 30 mg, 60 mg, 90 mg and 120 mg, etc. 30 mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Etoricoxib is widely used in various fields, such as Hospital, Pharmacy and Others,, etc. Hospital provides greatest supports to the Etoricoxib industry development. In 2022, global % sales of Etoricoxib went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Etoricoxib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Morepen Laboratories
Merck & Co
Frosst Iberica SA
Metrochem API
Atom Pharma
Hema Pharmaceuticals
Beijing Tide Pharmaceutical
Qilu Pharmaceutical
Shanghai Shyndec Pharmaceutical
Easton Biopharmaceuticals
Segment by Type
30 mg
60 mg
90 mg
120 mg
Hospital
Pharmacy
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Etoricoxib market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Etoricoxib, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Etoricoxib industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Etoricoxib in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Etoricoxib introduction, etc. Etoricoxib Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Etoricoxib market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Etoricoxib report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Etoricoxib market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Etoricoxib industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Etoricoxib key manufacturers include Morepen Laboratories, Merck & Co, Frosst Iberica SA, Metrochem API, Atom Pharma, Hema Pharmaceuticals, Beijing Tide Pharmaceutical, Qilu Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. Morepen Laboratories, Merck & Co, Frosst Iberica SA are top 3 players and held % sales share in total in 2022.
Etoricoxib can be divided into 30 mg, 60 mg, 90 mg and 120 mg, etc. 30 mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Etoricoxib is widely used in various fields, such as Hospital, Pharmacy and Others,, etc. Hospital provides greatest supports to the Etoricoxib industry development. In 2022, global % sales of Etoricoxib went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Etoricoxib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Morepen Laboratories
Merck & Co
Frosst Iberica SA
Metrochem API
Atom Pharma
Hema Pharmaceuticals
Beijing Tide Pharmaceutical
Qilu Pharmaceutical
Shanghai Shyndec Pharmaceutical
Easton Biopharmaceuticals
Segment by Type
30 mg
60 mg
90 mg
120 mg
Segment by Application
Hospital
Pharmacy
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Etoricoxib market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Etoricoxib, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Etoricoxib industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Etoricoxib in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Etoricoxib introduction, etc. Etoricoxib Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Etoricoxib market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.